The global orthobiologics market size was generated $4.93 billion in 2018 and is projected to reach $6.93 billion by 2026, registering a CAGR of 4.7% from 2019 to 2026. The research offers a detailed analysis on changing market dynamics, key investment pockets, major segments, and market competition.
Surge in global geriatric population, which is prone to various diseases such as osteoarthritis and others, increase in awareness of orthobiologics, rise in demand for advanced treatment, surge in obesity, and rise in number of sports and road accidents are other factors that drive the growth of the global orthobiologics market. However, higher cost of orthobiologics and stringent approval process restrain the growth of the market. Conversely, high growth potential in developing nations and upsurge in demand for advanced treatment create new opportunities for the market growth.
Viscosupplementation products segment to be lucrative through 2026
Among products, the viscosupplementation products segment accounted for half of the overall market share in 2017 and would retain its dominance through 2026. The same would grow at the fastest CAGR of 4.8% during the forecast period. This is due to the increase in geriatric population, rise in prevalence of osteoarthritis, and growth in lifestyle-induced disorders, such as obesity.
Hospitals & ambulatory centers segment to be lucrative through 2026
Among end users, the hospitals & ambulatory centers segment was the largest in 2017, capturing 90% of the market share and would maintain its dominance through 2026. The same segment would grow at the fastest CAGR of 4.4% from 2018 to 2026. This is because these facilities are fully equipped for performing the surgeries and have the skilled professionals to carry out the procedures.
North America to be dominant, Asia-Pacific to exhibit the fastest growth through 2026
North America captured half of the market share in 2017 and is likely to dominate the market through 2026. This is due to rise in the elderly population, favorable reimbursement rates, rise in the prevalence of orthopedic disorders even among younger population, and increase in number of road accidents in the region. However, Asia-Pacific is expected to register the fastest CAGR of 5.7% from 2019 to 2026.
Key players of the industry
Leading market players analyzed in the research include Stryker Corporation, Zimmer Biomet Holdings, Inc., Wright Medical Group, Inc., Integra LifeSciences Holdings Corporation, Arthrex, Inc. (Arthrex), Johnson and Johnson (J&J), Exactec Inc., Medline Industries, Inc., Globus Medical, Inc., and NuVasive Inc. These market players have adopted various strategies including collaborations, joint ventures, partnerships, expansions, and others to gain a strong position in the industry.
Demineralized Bone Matrix (DBM)
Bone Morphogenetic Protein (BMP)
Synthetic Bone Substitutes
Wrist & Shoulder
Osteoarthritis & Degenerative Arthritis
Soft Tissue Injuries
Maxillofacial & Dental Applications
By End User
Hospitals & Ambulatory Centers
Research & Academic Institute
The report analyzes and forecasts the orthobiologics market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global orthobiologics market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the orthobiologics market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of orthobiologics market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Global Tumor Ablation Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026Read more...
Global Minimally Invasive Surgical Instruments Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026Read more...
Global Biosurgery Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026Read more...
Global Dental Implants Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026Read more...
Global Cell Analysis Market Size, Share, Growth, Trends, Company Analysis and Forecast 2019-2026Read more...